TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Opis bibliograficzny
1. autor:	Afroza, Halima
Kolejni autorzy:	Talukder, Mesbah
Format:	Praca dyplomowa
Język:	English
Wydane:	Brac University 2024
Hasła przedmiotowe:	Psoriasis Alopecia TNF-α inhibitor FAERS ROR Disproportionality analysis
Dostęp online:	http://hdl.handle.net/10361/22075

Podobne zapisy

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
od: Islam, Nahidul
Wydane: (2023)

Isolation and identification of α-amylase producing soil microorganisms and partial characterization of α-Amylase enzyme
od: Tamanna, Shams Tahsin
Wydane: (2020)

Safety and efficacy of dutasteride for male Androgenetic Alopecia
od: Islam, S.M. Zahidul
Wydane: (2024)

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
od: Khandker, Tahia Anjum
Wydane: (2024)

Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
od: Akter, Anika
Wydane: (2022)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
od: Meem, Manila
Wydane: (2023)

Inhibition of Fibroblast Activation Protein alpha (FAP-α) in Colorectal Cancer
od: Tabassum, Azwada
Wydane: (2021)

Identification of FAP inhibitors using in silico simulation study
od: Deeba, Maliha Tasnim
Wydane: (2018)

Biologics and Biosimilars as Treatment Options for Psoriasis
od: Moya, Amena Khatun
Wydane: (2023)

Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
od: Onanna, Kazi
Wydane: (2024)

Efficacy and safety of monotherapy and combination therapy of oral minoxidil for androgenetic alopecia: a structured review
od: Jahan, Safrin
Wydane: (2023)

A review on potential of PARP inhibitors in the treatment of prostate cancer
od: Islam, Saidul
Wydane: (2022)

Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
od: Bishakha, Adwiza Chakraborty
Wydane: (2024)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
od: Bakar, Osama Bin Abu
Wydane: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Flora, Sanzida Alam
Wydane: (2024)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
od: Karim, Azrin
Wydane: (2024)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
od: Oshin, Sadia Afrin
Wydane: (2021)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
od: Haque, Mushfiqul
Wydane: (2019)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
od: Mahin, Md. Tamjidur Rahman
Wydane: (2024)

Female Alopecia
od: TrÃ¼eb
Wydane: (2013)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
od: Khan, Muidul Hasan
Wydane: (2024)

Induced pluripotent stem cells: a novel tool for modelling and treating Parkinson’s disease
od: Tanin, Nahid Sultana
Wydane: (2022)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
od: Sorno, Rubina Haque
Wydane: (2024)

Detection of skin diseases using deep learning
od: Shodoy, Masuk Ur Rahman
Wydane: (2024)

Pharmacoepidemiology and Pharmacovigilance

Synthesis and sar o acne medication
od: Naureen, Tasnia
Wydane: (2024)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
od: Fred, Namanda Rogers
Wydane: (2021)

Importance of biologically active agents over other therapies in Rheumatoid Arthritis- a review
od: Mehreen, Elnaj
Wydane: (2021)

HPLC method development for the analysis of linagliptin
od: Mimiya, Ruhani Amrin
Wydane: (2020)

RIPK pathway, as a potential target, for cancer treatment - a review
od: Jahan, Nusrat
Wydane: (2024)

Importance of biologics in rheumatoid arthritis management
od: Riyadh, S. M.
Wydane: (2022)

Pharmacovigilance in the European Union
od: Kaeding
Wydane: (2017)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
od: Ratu, Tabassum
Wydane: (2024)

Pharmacoepidemiology and pharmacovigilance : synergistic tools to better Investigate drug safety /
od: Nour, Sabrina
Wydane: (2019)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
od: Ishrat, Nowshin
Wydane: (2024)

Immunotherapy in the Management of Lung Cancer
od: Tasnim, Humayra
Wydane: (2022)

Recent advances in Cancer treatment targeting autophagy and future aspects
od: Emon, Kamrul Hasan
Wydane: (2022)

Oral terbinafine-, fluconazole-, ravuconazole-, oteseconazole-induced hepatotoxicity and acute kidney injury in the treatment of onychomycosis: a pharmacovigilance study
od: Rahman, Towsifur
Wydane: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
od: Mirza, Maisa Tasnim
Wydane: (2023)

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
od: Rahman, Ahadina
Wydane: (2018)